FibroBiologics Closes Second $5 Million Tranche of $25 Million Financing
D. Boral Capital Served as Exclusive Placement Agent to FibroBiologics, Inc. (Nasdaq: FBLG) in connection with its $25.0 Million Financing
FibroBiologics, Inc. (NASDAQ: FBLG) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $16.00 price target on the stock.
FibroBiologics Announces $25 Million Financing
FibroBiologics, Inc. (NASDAQ: FBLG) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $12.00 price target on the stock.